Introduction {#sec1}
============

Several interventions are being used in food processing and production industry to control food contamination by pathogens. Food pathogens pose a serious problem to the health of the human kind. World Health Organization (WHO) has estimated that 420,000 people die every year due to contamination food ([@B32]). Bacteria contribute to 90% of the deaths due to food poisoning under which *Listeria monocytogenes* and *Escherichia coli* are responsible for 31% of the cases. United States Department of Agriculture (USDA) has reported 21 recalls due to *L. monocytogenes* and 9 recalls for Shiga-toxin producing *E. coli* (STEC) in 2018 in the US which has led to 4, 415, 454 pounds of product being recalled ([@B31]). There has been an increase in the number of contamination and prevalence of these pathogens in fresh produce including spinach. Recall of organic spinach and spring mix in 2012 due to STEC contamination in the US ([@B8]) and recall of baby spinach in Canada due to *L. monocytogenes* in 2018 ([@B6]) has caused significant loss and health issues to people.

Current measures to eliminate contamination of food by pathogens including heating, refrigeration, freezing, modified packaging, antimicrobial washes and addition of antimicrobials in the finished product. Most of the antimicrobials being used to control food contamination are synthetic and have limitations on efficacy. Also, as consumers are becoming aware of the ingredients, they seek for safe products with clean label antimicrobials.

Several strategies and approaches are being followed to develop clean label antimicrobial for food application including use of plant extracts ([@B15]), essential oils for plants and plant products ([@B25]) and use of beneficial microbes ([@B9]; [@B33]). Use of normal commensals and beneficial microbes from the environment and food sources have been studied and evaluated extensively. Food has been a good source of these beneficial microbes with activity against food pathogens ([@B34]). A major portion of the beneficial microbes isolated from food belong to the class lactic acid bacteria which produce multiple antimicrobial compounds including organic acid and bacteriocins. Lactic acid bacteria isolated from food are reported to possess antimicrobial activity against *E. coli* and *L. monocytogenes* ([@B1]). *Leuconostoc* spp. which falls under the lactic acid bacteria groups are also known to be effective against *E. coli*, *L. monocytogenes*, *Salmonella enterica* serovar Typhi and *S. enterica* serovar Typhimurium ([@B11]; [@B3]). *Leuconostoc* spp. have been isolated from several foods including such as chill-stored and fermented meats, vegetables, and dairy products ([@B19]). They have also been isolated from meat processing plants ([@B12]; [@B24]).

Previously, *Leuconostoc* spp. have been isolated from chicken and pork samples from Indian ([@B28]) which showed promising results against *E. coli*, *L. monocytogenes*, *Staphylococcus aureus* and *S.* Typhimurium. The objective of the present study was to evaluate the efficacy of the *Leuconostoc* isolates in controlling *E. coli* and *L. monocytogenes* in spinach stored at 4°C for a period of 5 d.

Materials and Methods {#sec2}
=====================

Experimental brief {#sec2-1}
------------------

Two challenge studies were conducted in spinach leaves with *E. coli* and *L. monocytogenes.* Spinach leaves were treated with cell free supernatants (CFSs) of the *Leuconostoc* isolates, then inoculated with the pathogen (*E. coli* and *L. monocytogenes)* and enumerated at regular intervals while stored at 4°C for 5 d. Each of the challenge study was conducted in triplicates with 2 sampling at each time point/replicate. The groups for the study included inoculated control with no antimicrobial treatment and 5 groups inoculated with pathogen and treated with CFS of the isolated. Detailed description of each of the step of the study, materials and methods are provided below.

Pathogens {#sec2-2}
---------

The food-borne pathogens that were selected for the study were *E. coli* MTCC 443, and *L. monocytogenes* MTCC 657. The strains were procured from MTCC, India. The samples were received as freeze-dried cultured in glass vials. Upon receiving the samples, the cultures were sub-cultured by inoculating the samples into 10 mL of sterile Tryptone Soya Broth (TSB, HiMedia M641, Chennai, India) and incubating for 24 h at 37°C. After the incubation period, sterile 50% glycerol on deionized water was added with the cultures at 1:1 ratio to make a final concentration of 25% glycerol (Sigma Aldrich, G9012) in the glycerol culture stocks. The samples were transferred to cryovials and were frozen at −80°C until further use.

Inoculum preparation {#sec2-3}
--------------------

The glycerol stock of the cultures (*E. coli* and *L. monocytogenes*) were thawed to room temperatures and 100 μL of strain from the stock were aseptically transferred to 10 mL of TSB broth and incubated at 37°C for 18--20 h. One hundred μL of the overnight culture was transferred again to 10 mL of TSB broth and incubated at 25°C for 18--20 h. After the incubation period, the cells were harvested by centrifugation (2,500×g, 20 min) and suspended in 10 mL of phosphate buffered saline pH 7.2 (PBS, HiMedia, M1452, Chennai, India). The working inoculum of the pathogens was prepared by diluting the cultures to achieve \~6 to 7 Log~10~ CFU/mL respectively. The counts of the working inoculum were verified by plating on to their selective media.

*Leuconostoc* isolates and cell-free supernatant (CFS) preparation {#sec2-4}
------------------------------------------------------------------

The *Leuconostoc* isolates designated as CM17, CM19, PM30, PM32, and PM36 were identified earlier as *Lc. mesenteroides* subsp*. mesenteroides* J18; CP003101, *Lc. mesenteroides* LM2, *Lc. mesenteroides* (T); ATCC 8293; CP000414, *Lc. gelidum* subsp*. gasicomitatum* LMG 18811; type strain: LMG 18811; FN822744 and *Lc. mesenteroides*; LM2; AY675249 respectively. Glycerol stocks of these isolates were passaged twice in De Man, Rogosa and Sharpe (MRS) broth (HiMedia, M369) and incubated for 24°C for 48 h. The samples were centrifuged at 2,500×g for 20 min to remove all cells and the CFSs were used for the antimicrobial treatment. The CFSs were stored in the refrigerator until use within the same day.

Spinach samples {#sec2-5}
---------------

Spinach leave samples (Semi-savoy type) were procured from the local vegetable market, they were cleaned with water to remove dirt, air drier to remove excess moisture. The leaves were packed in 25 g into Ziploc pouches and stored in refrigerator until use. The samples were inoculated with the pathogen on the same day.

Inoculation and treatment of the spinach samples {#sec2-6}
------------------------------------------------

Twenty-five gram of the spinach leaves in the Ziploc pouches were inoculated with 250 μL of the working inoculum of either *E. coli* or *Listeria*. The pouches were hand massage gently to help with distribution of the inoculum over the leaves. The samples were allowed to stand for 60 min at room temperature to enable the attachment of the pathogens to the leaves. After 60 min, each of the groups was treated with 1 mL of one of *Leuconostoc* CFS. Control samples treated with only MRS broth was maintained to compare with the treatment groups.

Storage of the samples {#sec2-7}
----------------------

Ziploc pouches containing the spinach leaves were stored at 4°C for 5 d and enumerated for the counts of pathogens at regular intervals. The samples were spread out in the refrigerator to enable uniformity in the temperature. This storage condition and duration was followed to mimic the typical consumers practice.

Enumeration of the spinach leaves for pathogens {#sec2-8}
-----------------------------------------------

The samples were enumerated for the counts of pathogens on 0, 1, 2, and 5 d of storage. Twenty-five milliliters of PBS was added to each of the pouch, hand massaged to facilitate the detachment of the cells and aliquots were serially diluted and plated using selective media for the pathogens. In the case of *Listeria*, Listeria Identification Agar Base (PALCAM, HiMedia M1064, Chennai, India) supplemented with Listeria Selective Supplement (PALCAM) (FD061) was used as the plating media whereas in the case of *E. coli*, Levine Eosin-Methylene Blue Agar Medium (EMB agar, Himedia MU022). Both PALCAM and EMB were incubated at 37°C for 24 to 48 h. After the incubation period, the colonies were counted and represented as Log~10~ colony forming unit CFU/mL of the rinse. Control samples of the leaves with no microbial inoculation were enumerated on 0 d to rule out any background contamination from the leaves. Two samples per group were tested per time period and the study was conducted in three replicates.

Statistical analysis {#sec2-9}
--------------------

The data from the enumeration studies are reported as average Log~10~ CFU/mL of rinse±SD for three separate studies (n=3) conducted for each of challenge studies with *E. coli* and *L. monocytogenes*. Differences between the treatments and the untreated control were analyzed by one-way analysis of variance (ANOVA) using the STATGRAPHICS^©^ Centurion XV. All statistically significant differences in the study were reported at p\<0.05 level.

Results and Discussion {#sec3}
======================

Antimicrobial activity of the CFS against *L. monocytogenes* {#sec3-1}
------------------------------------------------------------

Uninoculated control spinach leaves were plated on 0 d onto PALCAM agar to rule out any background *Listeria* contamination in the samples and the leaves were found to be free of *Listeri*a. The study showed that *L. monocytogenes* did not grow significantly (p=0.4406) in the inoculated control samples when stored at 4°C for 5 d ([Table 1](#T1){ref-type="table"}). Despite the fact that *Listeria* can survive and thrive at refrigerated condition, there was no growth observed within the 5 d of testing period. This is in alignment with the previous observations ([@B7]) wherein a 5.6 d lag phase was observed with *L.* *monocytogenes* in ready-to-eat iceberg lettuce stored at 5°C. The longer time period would have witnessed growth of *Listeria* in the leaves, however, 5 d was chosen as it is the traditional shelf life of spinach. In the case of the leaves treated with the CFS of the *Leuconostoc* isolates, they did not show any difference (p=0.8621) in the counts of *Listeria* at 0 d as compared to the control. However, at 1, 2, and 5 d all the groups treated with the CFS showed significant reduction (p\<0.05) in the Log~10~ CFU/mL of the rinse as compared to the control ([Fig. 1](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). The % of reduction in the counts ranged from 30.75% to 73.28% on 1 d reaching up to 64.16% to 89.95% on 5 d ([Table 1](#T1){ref-type="table"}). CFS of *Leuconostoc* isolate CM19 (*Lc. mesenteroides* LM2) showed the least reduction by the end of 5 d (64.19%) whereas isolates PM 30 (*Lc. mesenteroides* (T); ATCC 8293; CP000414) and PM32 (*Lc. mesenteroides*; LM2; AY675249) showed the highest reduction throughput the study period, with 85.75% and 89.95% respectively on 5 d. Earlier study by [@B23] showed the inhibitory effect of *Leuconostoc* isolated from a fermented fish dish on *L. monocytogenes* infection in A/J mice and in Caco-2 cells. Similarly, *Leuconostoc* isolated from fresh fruits and vegetables were found to efficient in controlling *Listeria* in wounds of Golden Delicious apples and iceberg lettuce leaf cuts ([@B30]). One of the strain CM 160 was most effective resulting in a ten-fold reduction of the viable pathogen concentration (ED90) which is close to the efficacy observed with PM 36 (90% reduction).

![Antimicrobial activity of the cell free supernatant (CFS) of the *Leuconostoc* isolates against *Listeria monocytogenes* MTCC 657 and *Escherichia coli* MTTC 443 in spinach stored at 4°C for a period of 5 d.\
Values represented are average CFU/mL of the rinse±SD. n=3. EC in the graph refers to *E. coli* and LM to *L. monocytogenes*. MTCC, microbial type culture collection and gene bank.](kosfa-39-4-677-g1){#F1}

###### Antimicrobial activity of the cell free supernatant (CFS) of the *Leuconostoc* isolates against *Listeria monocytogenes* MTCC 657 in spinach stored at 4°C for a period of 5 days represented as average Log~10~ CFU/mL of rinse of the different groups at different time points

  Groups     Log~10~ CFU/mL of rinse^[1)](#TN2){ref-type="table-fn"}^                    \% of reduction over control^[2)](#TN5){ref-type="table-fn"}^                                                                                                                                                                                              
  ---------- --------------------------------------------------------------------------- --------------------------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- ------ ------ ------ ------
  Control    5.81± 0.08^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^   5.91±0.04^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.89±0.08^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^     5.85±0.09^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^     N/A    N/A    N/A    N/A
  CM17 CFS   5.7± 0.24^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.38±0.16^[c](#TN3){ref-type="table-fn"},[xy](#TN4){ref-type="table-fn"}^   5.42±0.04^[b](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^     5.35±0.12^[bc](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^    22.3   71.0   65.8   68.7
  CM19 CFS   5.73±0.07^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.75±0.13^[b](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.42±0.08^[b](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^     5.41±0.03^[b](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^     18.0   30.8   66.3   64.2
  PM30 CFS   5.79±0.06^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.35±0.10^[c](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^    5.09±0.07^[bc](#TN3){ref-type="table-fn"},[yz](#TN4){ref-type="table-fn"}^   5.01±0.014^[cd](#TN3){ref-type="table-fn"},[z](#TN4){ref-type="table-fn"}^   6.2    72.9   84.1   85.8
  PM32 CFS   5.76±0.11^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.46±0.10^[c](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^    5.39±0.07^[bc](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^    5.28±0.06^[bcd](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^   11.3   65.0   68.4   73.2
  PM36 CFS   5.78±0.09^[a](#TN3){ref-type="table-fn"},[x](#TN4){ref-type="table-fn"}^    5.34±0.29^[c](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^    5.24±0.24^[c](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^     4.86±0.07^[d](#TN3){ref-type="table-fn"},[y](#TN4){ref-type="table-fn"}^     7.2    73.3   77.8   90.0

n=3, p\<0.05.

Cells with different alphabets represent statistical difference.

represents statistical difference between the groups at a specific testing period whereas

represents statistical difference within a group over time.

The % of reduction represented for the antimicrobial treatment groups indicate % reduction over the control at a specific testing time point.

MTCC, microbial type culture collection and gene bank.

Statistical analysis of the counts of *Listeria* within the group over the testing period showed significant reduction from 1 d in all the groups treated with CFS except for CM 17 which showed reduction from 2 d. Within the groups that showed the efficacy from 1 d, no statistically significant difference was observed beyond 1 d expect from PM 30 which showed a gradual reduction over the entire testing period to reach 85.75% reduction by the end ([Table 1](#T1){ref-type="table"}).

Antimicrobial activity of the CFS against *E. coli* {#sec3-2}
---------------------------------------------------

Plating of the uninoculated control spinach leaves on 0 d for *E. coli* showed that the sample was free of the *E. coli* that could picked in the EMB agar. No statistically significant difference (p=0.2857) were observed in the count of *E. coli* in the inoculated control samples when stored at 4°C, over the 5 d testing period ([Table 2](#T2){ref-type="table"}). Leaves treated with the *Leuconostoc* CFSs, they did not show any difference (p=0.4037) in the counts of *E. coli* at 0 d as compared to the control. However, from 1 d all the antimicrobial treated groups showed significant reduction (p\<0.05) in the Log~10~ CFU/mL of the rinse as compared to the control ([Fig. 1](#F1){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). The percentage of reduction in the counts ranged from 61.70% to 88.37% on 1 d reaching up to 79.69% to 97.35% on 5 d ([Table 2](#T2){ref-type="table"}). As observed with *Listeria*, CFS of *Leuconostoc* isolate CM19 showed the least reduction by the end of 5 d (79.69%) and isolates PM 30 and PM32 showed the highest reduction throughput the study period, with 95.21% and 97.35% respectively on day 5. *Leuconostoc* isolated from ground beef was found to inhibit *E. coli* O157 H7, *S. aureus*, *Salmonella* spp., *L. monocytogenes*, and spoilage bacteria *Brochothrix thermosphacta* in beef ([@B17]). The activity of the CFS of the isolate was attributed to organic acids produced by the isolates. Similarly, *Lc. mesenteroides* KCCM35046 fermented aged garlic extract were found to be effective in controlling *E. coli* in the excreta of chicken ([@B16]).

###### Antimicrobial activity of the cell free supernatant (CFS) of the *Leuconostoc* isolates against *Escherichia coli* MTTC 443 in spinach stored at 4°C for a period of 5 days represented as average Log~10~ CFU/mL of rinse of the different groups at different time points

  Groups     Log~10~ CFU/mL of rinse^[1)](#TN8){ref-type="table-fn"}^                    \% of reduction over control^[2)](#TN11){ref-type="table-fn"}^                                                                                                                                                                                            
  ---------- --------------------------------------------------------------------------- ---------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------- ------ ------ ------ ------
  Control    7.29±0.10^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   7.32±0.15^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^    7.41±0.13^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   7.51±0.19^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   N/A    N/A    N/A    N/A
  CM17 CFS   7.16±0.05^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   6.79±0.14^[bc](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.61±0.15^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.52±0.16^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   26.4   70.5   84.0   89.9
  CM19 CFS   7.03±0.06^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   6.90±0.08^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^    6.79±0.07^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.82±0.04^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   44.9   61.7   76.2   79.7
  PM30 CFS   7.18±0.34^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   6.67±0.17^[bc](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.45±0.62^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.19±0.15^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   23.5   77.7   89.0   95.2
  PM32 CFS   6.97±0.06^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   6.79±0.07^[bc](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.82±0.05^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   6.56±0.09^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   52.9   70.3   74.4   88.9
  PM36 CFS   7.12±0.32^[a](#TN9){ref-type="table-fn"},[x](#TN10){ref-type="table-fn"}^   6.38±0.01^[c](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^    6.04±0.07^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   5.94±0.04^[b](#TN9){ref-type="table-fn"},[y](#TN10){ref-type="table-fn"}^   33.5   88.4   95.7   97.4

n=3, p\<0.05.

Cells with different alphabets represent statistical difference.

represents statistical difference between the groups at a specific testing period whereas

represents statistical difference within a group over time.

The % of reduction represented for the antimicrobial treatment group indicates % reduction over the control at a specific testing time point.

The counts of *Listeria* within the group over the testing period showed significant reduction from 1 d in all the groups treated with CFS except for the control. No significant difference was observed in the counts in any of the groups beyond 1 d indicating that the inhibition was achieved with 24 h and no further statistical reduction was observed. However, numerical difference was observed after 1 d in all groups except for CM 19 ([Table 2](#T2){ref-type="table"}).

Over all, the study showed that the CFSs of the *Leuconostoc* isolates from Indian meat were able to reduce the counts of *L. monocytogenes* and *E. coli* in spinach leaves. PM 36 isolate (*Lc. mesenteroides*; LM2; AY675249) was found to be the most potent of all the isolates with 90 and 95% reduction in the pathogens at the end of 5 d. PM 32 (*Lc. gelidum* subsp*. gasicomitatum* LMG 18811) also showed high reduction in the pathogens.

*Leuconostoc* spp. isolated from different sources has been reported to possess antimicrobial activity by several researchers ([@B5]; [@B2]). The antimicrobial activity of *Leuconostoc* have been attributed to production of organic acid ([@B17]) and bacteriocins ([@B14]; [@B20]). Several bacteriocins are being produced by *Lc. mesenteroides*, including Leucocin A-VAL 187, Leucocin A, Mesentericin YlOS, Bacteriocin ST33LD, Leucocyclicin Q ([@B21]; [@B27], [@B29]). Use of *Leuconostoc* in food applications has been studied by [@B26], where in the Leucocin K7 produced by *Leuconostoc mesenteroides* K7 isolated from fermented pickle was found to be effective in controlling *L monocytogenes* for a period of 7 d in milk. Similarly, novel bacteriocins isolated from *Lc. mesenteroides* spp. *mesenteroides* IMAU:10231 were found to be effective in *Listeria* control in Serbian Sremska sausages ([@B22]). [@B13] demonstrated the efficacy of *Leuconostoc gelidum* against closely related species and *L. monocytogenes.* However, no efficacy was found against spore forming and other gram-positive bacteria like *S. aureus*. This is contrary to the promising results that we have obtained with our strain.

*Leuconostoc* spp. has been isolated from multiple and different habitats and they play an integral role in the fermentation of food. *Leuconostocs* are generally considered as GRAS (generally regarded as safe) organisms ([@B4]) as they are associated with food fermentation. However, some species of *Leuconostoc* have been associated with opportunistic infection ([@B18]) in immune compromised patients and this microorganism can cause spoilage in some types of food matrices ([@B10]).

Although these microbial strains may have a negative impact in food application due to their ability to cause food spoilage by slime, rope formation and imparting sourness, the CFSs can be a potential biopreservative to control food pathogens in food. This would be a potential clean label antimicrobial to replace existing synthetic antimicrobials in the food.
